Skip to main navigation Skip to search Skip to main content

Veliparib in Combination With Platinum- Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study

  • Suresh S. Ramalingam*
  • , Silvia Novello
  • , Salih Zeki Guclu
  • , Dmitry Bentsion
  • , Zanete Zvirbule
  • , Maria Szilasi
  • , Reyes Bernabe
  • , Konstantinos Syrigos
  • , Lauren Averett Byers
  • , Philip Clingan
  • , Jair Bar
  • , Everett E. Vokes
  • , Ramaswamy Govindan
  • , Martin Dunbar
  • , Peter Ansell
  • , Lei He
  • , Xin Huang
  • , Vasudha Sehgal
  • , Jaimee Glasgow
  • , Bruce A. Bach
    • Julien Mazieres
*Corresponding author for this work
  • Emory University
  • National and Kapodistrian University of Athens
  • University of Turin
  • Izmir Chest Diseases Research Hospital
  • Ozel Gazi Hospital
  • Sverdlovsk Regional Oncology Center
  • Riga East University Hospital
  • University of Debrecen
  • Hospital Universitario Virgen del Rocio
  • University of Texas MD Anderson Cancer Center
  • Southern Medical Day Care Centre
  • Sheba Medical Center at Tel Hashomer
  • The University of Chicago
  • Washington University St. Louis
  • AbbVie
  • CHU de Toulouse

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Veliparib in Combination With Platinum- Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science